Gwenn Hansen

Chief Scientific Officer, Nurix Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.7M

Companies

Latest trade

Oct 15, 2026

Companies

Nurix Therapeutics, Inc.Chief Scientific Officer −$0.7M

Trades

NRIX Sold 1,452 shares at $25.00 · planned $0.0M Oct 15

NRIX Sold 1,452 shares at $25.47 · planned $0.0M Sep 1

NRIX Sold 4,356 shares at $25.00 · planned $0.1M Aug 5

NRIX Sold 4,111 shares at $24.36 · planned $0.1M Aug 4

NRIX Sold 3,847 shares at $23.38 $0.1M Jul 30

NRIX Sold 5,394 shares at $20.00 · planned $0.1M Jun 25

NRIX Sold 3,214 shares at $16.65 $0.1M Apr 30

NRIX Sold 4,895 shares at $16.60 $0.1M Jan 30

NRIX Sold 4,087 shares at $12.80 $0.1M Oct 30

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.